Dementia
📧 Sign up to get email alerts when something new happens for Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Context- and Terrain-aware Gait Analysis
A University of Leeds clinical trial evaluating context- and terrain-aware gait analysis in Parkinson's disease, dementia, and related condi…
-
CLINICAL_TRIALS withdrawal · 2026-02-23Clinical Trial Update: Evaluating a Wearable Tracking System for Family Caregivers of Persons With Dementia With Wandering Concerns [NA]
The clinical trial evaluating a wearable tracking system for family caregivers of people with dementia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-02Clinical Trial Update: Dementia Prevention Internet-Based Intervention: Randomized Controlled Trial and Knowledge Translation [NA]
This clinical trial update indicates that the randomized controlled trial of an internet-based dementia prevention intervention has been wit…
-
CLINICAL_TRIALS withdrawal · 2024-07-05Clinical Trial Update: Dronabinol for Agitation in Dementia Crossover Trial [Phase 2]
A Phase 2 crossover trial evaluating dronabinol for agitation in patients with dementia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-22Clinical Trial Update: Improving Wellbeing and Health for Care Home Residents During COVID-19 [NA]
The clinical trial NCT04590469 investigating wellbeing and health for care home residents with dementia during COVID-19 has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2019-01-18Clinical Trial Update: Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
A clinical trial from Uniformed Services University investigating dementia types that may occur after traumatic brain injury in retired mili…
-
CLINICAL_TRIALS withdrawal · 2016-05-03Clinical Trial Update: Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease [Phase 3]
A Phase 3 study evaluating two doses of EVP-6124 in Alzheimer's disease was terminated.
-
CLINICAL_TRIALS withdrawal · 2015-10-15Clinical Trial Update: Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine [Phase 2]
Phase 2 study evaluating the safety of two doses of EVP-6124 in people with Alzheimer's disease who are receiving memantine has been withdra…
-
CLINICAL_TRIALS withdrawal · 2015-05-27Clinical Trial Update: Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients [Phase 4]
This report indicates that the Phase 4 trial evaluating safety and efficacy of divalproex in combination with quetiapine for elderly patient…
-
EMA withdrawal · 2012-09-27EMA Withdrawn: Rivastigmine Teva (rivastigmine) — Teva Pharma B.V.
The EMA withdrew Rivastigmine Teva (rivastigmine) from its European market authorization.